U.S., May 29 -- ClinicalTrials.gov registry received information related to the study (NCT06992401) titled 'Observational Study of Intranasal IVIG and RXRA Gene Expression in Long COVID Patients Undergoing Medical Tourism' on May 23.
Brief Summary: This observational study is being conducted by Healing Hope International to collect real-world data on an emerging treatment approach for Long COVID in patients with immunodeficiency. The study explores the relationship between the RXRA gene and neuroinflammation and investigates the effects of intranasal immunoglobulin (IVIG) therapy in a real-world setting.
Participants will be individuals diagnosed with Long COVID who have confirmed immunodeficiency, such as low IgG or IgA levels or specifi...